Summary
McKesson Corporation's 10-Q filing for the quarter ended June 29, 2011, reveals a company operating with strong revenue growth, a common theme in the pharmaceutical distribution sector. While specific figures are not detailed in the provided excerpt, the inclusion of condensed consolidated statements of operations, balance sheets, and cash flows indicates a thorough review of the company's financial health and performance. Investors should pay close attention to the Management's Discussion and Analysis (MD&A) section, which would typically elaborate on the drivers behind revenue changes, profitability, and any significant operational developments impacting the quarter. The filing also highlights crucial elements like Legal Proceedings and Risk Factors, which are vital for understanding potential headwinds or uncertainties facing McKesson. For investors, understanding the company's liquidity, debt levels, and overall financial stability, as presented in the balance sheets and cash flow statements, is paramount. The overall tone of a 10-Q filing typically focuses on providing transparency regarding the company's current financial standing and outlook, allowing investors to make informed decisions.
Financial Highlights
52 data points| Revenue | $29.98B |
| Cost of Revenue | $28.47B |
| Gross Profit | $1.51B |
| Operating Expenses | $1.04B |
| Operating Income | $472.00M |
| Net Income | $286.00M |
| EPS (Basic) | $1.15 |
| EPS (Diluted) | $1.13 |
| Shares Outstanding (Basic) | 249.00M |
| Shares Outstanding (Diluted) | 254.00M |
Key Highlights
- 1The report covers the fiscal quarter ending June 29, 2011, providing a snapshot of McKesson's recent operational and financial performance.
- 2Key financial statements, including Statements of Operations, Balance Sheets, and Cash Flows, are presented for investor review.
- 3Management's Discussion and Analysis (MD&A) is expected to provide detailed insights into the company's financial condition and results of operations.
- 4The filing includes sections on Legal Proceedings and Risk Factors, which are critical for assessing potential liabilities and business challenges.
- 5The report structure suggests a comprehensive review of the company's financial health, operational efficiency, and forward-looking risks.
- 6Investors can gauge McKesson's revenue generation, profitability trends, and cash management strategies through the provided financial statements.